MarketScreener Homepage > Equities > NASDAQ OMX COPENHAGEN > Genmab A/S GMAB DK0010272202

Report

Real-time Estimate CHI-X - 12/03 08:47:13 am
2356.5	DKK		-0.11%

12/01

GENMAB A/S : Investor Presentation - December 2020

11/25

NOVARTIS : Genmab Announces Enapotamab Vedotin Update

11/24

GENMAB A/S : Announces Enapotamab Vedotin Update

Calendar

Upcoming events on GENMAB A/S

12/05/20 \| 03:45pm		American Society of Hematology Meeting - Updated Phase 1 Results of Teclistamab, a B-cell Maturation
12/05/20 \| 05:00pm		American Society of Hematology Meeting - A Phase 1, First-in-Human Study of Talquetamab,
12/06/20 \| 03:00pm		AMERICAN SOCIETY OF HEMATOLOGY MEETING - APOLLO: Phase 3 Randomized Study of Subcutaneous Daratumuma
12/06/20 \| 03:30pm		American Society of Hematology Meeting - Subcutaneous Epcoritamab Induces Complete Responses With an

Past events on GENMAB A/S

11/17/20 \| 09:40am		Jefferies Healthcare Conference
11/13/20 \| 08:30am		Capital Markets Day
11/11/20		Society of Immunotherapy of Cancer Meeting - DuoBody-CD3x5T4
11/11/20		Society of Immunotherapy of Cancer Meeting - Tisotumab vedotin

Upcoming sector events for GENMAB A/S

12/03/20		IONIS PHARMACEUTICALS, INC. : Piper Sandler Health Care Conference
12/03/20 \| 10:45am		ASCENDIS PHARMA A/S : Evercore ISI HealthCONx Virtual Conference
12/03/20 \| 11:20am		KODIAK SCIENCES INC. : Evercore ISI HealthCONx Conference
12/03/20 \| 02:15pm		NOVAVAX, INC. : Evercore ISI HealthCONx Conference

More events

Past sector events for GENMAB A/S

12/02/20 \| 01:00pm		ULTRAGENYX PHARMACEUTICAL INC. : Evercore ISI HealthCONx Conference
12/02/20 \| 11:20am		GILEAD SCIENCES, INC. : Evercore ISI HealthCONx Conference
12/02/20 \| 08:00am		REGENERON PHARMACEUTICALS, INC. : Piper Sandler Health Care Conference
12/02/20		NOVAVAX, INC. : Investor Meeting

Annual publications

Annual results		2015	2016	2017	2018	2019	2020 (e)
Sales M DKK	Released Forecast Spread	1 133 1 111 2,0%	1 816 1 804 0,69%	2 365 2 325 1,7%	3 025 2 905 4,1%	5 366 5 159 4,0%	9 831
Operating income (EBITDA) M DKK	Released Forecast Spread	762 659 16%	1 094 976 12%	1 414 1 315 7,6%	1 468 1 431 2,6%	2 777 2 460 13%	6 075
Operating profit (EBIT) M DKK	Released Forecast Spread	730 640 14%	1 053 1 016 3,7%	1 344 1 250 7,5%	1 380 1 388 -0,54%	2 638 2 372 11%	5 947
Pre-Tax Profit (EBT) M DKK	Released Forecast Spread	758 551 37%	1 130 1 022 11%	1 064 1 211 -12%	1 612 1 512 6,6%	2 859 2 705 5,7%	5 959
Net income M DKK	Released Forecast Spread	764 682 12%	1 187 977 22%	1 104 1 053 4,8%	1 472 1 281 15%	2 166 2 085 3,9%	4 689
EPS DKK	Released Forecast Spread	12,6 11,8 6,5%	19,2 16,2 19%	17,8 17,4 2,0%	23,7 20,8 14%	34,0 32,8 3,6%	72,2
Announcement Date		02/17/2016	02/22/2017	02/21/2018	02/20/2019	02/19/2020

Quarterly publications

Previous period

Next period

Quarterly results		2016 S1	2017 S1	2018 Q2	2018 S1	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 S1	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 S1	2020 Q3	2020 Q4 (e)	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)
Sales M DKK	Released Forecast Spread	524 496 5,7%	1 024 889 15%	510 556 -8,3%	1 191 1 147 3,8%	598 629 -5,0%	1 236 1 147 7,8%	591 710 -17%	774 747 3,6%	1 365 1 369 -0,29%	1 040	2 961 2 755 7,5%	892 894 -0,21%	5 451 5 457 -0,11%	6 343 6 164 2,9%	1 724 1 475 17%	1 797	1 221	1 711	2 064	2 931
Operating income (EBITDA) M DKK	Released Forecast Spread	155	605 449 35%	80,8	418	404	732	52,8	169	125 189 -34%	358 307 16%	2 294 1 911 20%	78,0 64,1 22%	4 505 4 564 -1,3%	4 583 4 480 2,3%	868 549 58%	604	118	282	698	1 548
Operating profit (EBIT) M DKK	Released Forecast Spread	158 138 15%	582 427 36%	135 245 -45%	459 392 17%	200 253 -21%	721 726 -0,74%	-25,9 90,2 -129%	137 83,5 64%	111 116 -4,3%	351	2 176 1 927 13%	71,0 60,5 17%	4 497 4 534 -0,82%	4 568 4 389 4,1%	858 451 90%	574	163	472	793	1 394
Pre-Tax Profit (EBT) M DKK	Released Forecast Spread	157 117 34%	411 407 1,2%	335 219 53%	591 323 83%	231 233 -1,2%	790 760 4,0%	94,0 142 -34%	111 161 -32%	205 250 -18%	699	1 955 1 833 6,7%	354 67,5 425%	4 328 4 557 -5,0%	4 682 4 682 0,00%	671 470 43%	523	176	442	639	1 236
Net income M DKK	Released Forecast Spread	157 117 34%	323 326 -0,84%	261 214 22%	459 252 82%	179 205 -13%	834 649 29%	72,2 111 -35%	84,9 134 -37%	157 225 -30%	537	1 472 1 401 5,0%	269 76,8 250%	3 378 3 638 -7,2%	3 647 4 573 -20%	530 380 39%	428	137	344	496	957
EPS	Released Forecast Spread	2,54 1,90 34%	5,21 5,40 -3,5%	4,21 3,45 22%	7,41 4,10 81%	2,89 3,39 -15%	13,4 10,4 29%	1,17 1,80 -35%	1,35 1,67 -19%	2,53 3,70 -32%	0,83 3,39 -76%	25,8 21,6 19%	4,09 1,19 244%	51,4 55,8 -8,0%	55,5 70,2 -21%	8,04 5,93 36%	6,58	2,09	5,22	7,55	14,6
Announcement Date		08/09/2016	08/09/2017	08/08/2018	08/08/2018	11/14/2018	02/20/2019	05/08/2019	08/14/2019	08/14/2019	11/06/2019	02/19/2020	05/06/2020	08/12/2020	08/12/2020	11/04/2020

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise